May 2026Machine learning risk stratification in a US-based database to identify subgroups of patients with head and neck cancer who benefit from adding chemotherapy to pembrolizumabComparative effectivenessHead and neck cancerArtificial intelligence
May 2021Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinomaHead and neck cancerTreatment and Testing patterns
February 2020Real-world treatment patterns and time on treatment (rwToT) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) with disease progression on or after platinum-containing chemotherapy in United States (U.S.)Head and neck cancerTreatment and Testing patterns
June 2019Organ dysfunction and clinical outcomes in patients treated with immune checkpoint inhibitorsUnmet needHead and neck cancerKidney cancerSkin cancerLung cancerGastric cancer
April 2019Development and initial validation of a prognostic score based on structured data from EHRsMethodologyHead and neck cancerKidney cancerSkin cancerLung cancerBladder cancer